--- https://www.cen-neurologie.fr/second-cycle/hemorragie-meningee-non-traumatique France educational course Other Preoperative IV Medications were not Administered EGFR Amplification Analysis Was Not Performed MGMT Promoter Methylation Testing Was Not Performed Physician Diagnosed Diabetes Absent Preoperative IV Antacids were not Administered ERBB2 Mutation Analysis Was Not Performed IDH Family Mutation Analysis Was Not Performed ATRX Gene Mutation Negative Unemployed Neither Case or Control Status Chemotherapy Not Received NON Mouse No History of Neonatal Complication Patient was Not Previously Evaluated for Current Chief Complaint BRAF Mutation Analysis Was Not Performed Fluorescence In Situ Hybridization Was Not Performed Adjuvant Post-operative Immunological Therapy Was Not Administered PDGFRA Mutation Analysis Was Not Performed Hypertension Absent Immunotherapy Was Not Administered as an Additional Treatment for a New Tumor Event ROS1 Rearrangement Analysis Was Not Performed No Known History of Alcohol Use Tumor Reoccurrence Absent After Initial Treatment History of Colorectal Cancer Negative Adjuvant Post-operative Targeted Molecular Therapy Was Not Administered Adjuvant Post-operative Pharmaceutical Therapy Was Not Administered New Disease is not Multifocal Preoperative IV Opiates were not Administered Additional Surgery for New Tumor Event Absent traumatic haemorrhage EGFR Mutation Analysis Was Not Performed ALK Rearrangement Analysis Was Not Performed Neither No Known History of Illicit Drug Use Intervention Not Given for Kawasaki Disease SDH Complex Mutation Analysis Was Not Performed Caffeine Not Routinely Consumed Regular Smokeless Tobacco Use for Six Weeks or More Negative Traumatic Hemorrhage Lymph Node Dissection Was Not Performed Subsequent Known Primary Melanoma(s) Not Found During the Follow-Up Not Lost to Follow-Up 1p/19q Deletion Analysis Was Not Performed Paraneoplastic Syndrome is Not Present BRAF Rearrangement Analysis Was Not Performed PTEN Gene Mutation Negative KRAS Mutation Analysis Was Not Performed Cancer History Absent Chief Complaint Not Caused by Trauma KIT Mutation Analysis Was Not Performed Evidence of Disease Absent after Completion of Therapy Has No Sibling Targeted Molecular Therapy Was Not Administered as an Additional Treatment for a New
Tumor Event Chemotherapy Was Not Administered as an Additional Treatment for a New Tumor Event History of Medical Treatment Absent Radiation Was Not Administered as an Additional Treatment for a New Tumor Event Medication Not Taken meningeal hemorrhage Peripheral Blood Immunophenotyping and Cytochemistry Were Not Performed Preoperative IV Sedation was Not Administered Adjuvant I-131 Therapy Negative Documentation Absent IDH Family Wildtype Norway Another Form of Birth Control was not Used No History of Rheumatic Fever Adjuvant Post-operative Radiation Therapy Was Not Administered subarachnoid hemorrhage, traumatic Nitric Oxide Measurement Nitric Oxide New Tumor Event After Initial Treatment Absent Patient was not Postmenopausal with no Prior Oophorectomy Therapeutic Ionizing Radiation to Head History Absent MET Mutation Analysis Was Not Performed No Response to Intervention for Kawasaki Disease Additional Surgery for New Metastatic Tumor Event Was Not Performed No History of Myopathy Minor Criteria for Rheumatic Heart Disease Not Present Negation Additional Immunohistochemistry Was Not Performed Any Metastatic Diagnosis Absent Meningeal NRAS Mutation Analysis Was Not Performed Regional Anesthesia was not Administered EGFR Gene Amplification Negative Local Anesthesia Agents were not Administered Additional Surgery for New Loco-Regional Tumor Event Was Not Performed Chief Complaint was Not Witnessed Routine Cytogenetics Were not Completed Multiple Known Primary Tumors Absent at Initial Melanoma Diagnosis Interferon Gamma Treatment was not Administered Prior to Specimen Resection No History of Other Muscular Dystrophy or Glycogen Storage Disorder 10q23/PTEN Locus Deletion Analysis Was Not Performed Radiation Therapy Not Received No History of Congenital Heart Disease First Degree Family History Thyroid Cancer Negative Additional Molecular Studies Were Not Performed ATRX Mutation Analysis Was Not Performed Interferon Gamma Treatment was not Administered 90 Days Prior to Specimen Resection TP53 Mutation Analysis Was Not Performed No History of Non-Cardiac Surgery Preoperative IV Antiemetics were not Administered Hormone Therapy Was Not Administered as an Additional Treatment for a New Tumor Event No History of Kawasaki Disease Family History of Stomach Cancer Absent Adjuvant Post-operative Chemotherapy Was Not Administered Chemical/Occupational Exposure Absent PTEN Mutation Analysis Was Not Performed NF1 Mutation Analysis Was Not Performed RET Rearrangement Analysis Was Not Performed No History of Gestational Complication Intercurrent Illness is Absent at Onset of Chief Complaint Radiation History Negative IV Anesthesia was not Administered Bone Marrow Aspirate Immunophenotyping and Cytochemistry Were Not Performed Tumor Progression Absent After Initial Treatment First Degree Family History of Primary Brain Tumor Negative First Degree Family History Cancer Negative Use of Smokeless Tobacco at Time of Diagnosis Negative